Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.

<h4>Background</h4>Despite China's Expanded Program on Immunization (EPI) provides 2 doses of group A and group C meningococcal polysaccharide vaccine (MPV-AC) for children at 3 years and 6 years old, more self-paying group ACYW135 meningococcal polysaccharide vaccines (MPV-ACYW135)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xinren Che, Yan Liu, Jun Wang, Yuyang Xu, Xuechao Zhang, Wenwen Gu, Wei Jiang, Jian Du, Xiaoping Zhang
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/32a1da62d2ae40d69213914a85b7731e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:32a1da62d2ae40d69213914a85b7731e
record_format	dspace
spelling	oai:doaj.org-article:32a1da62d2ae40d69213914a85b7731e2021-11-25T05:54:14ZBooster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.1932-620310.1371/journal.pone.0251567https://doaj.org/article/32a1da62d2ae40d69213914a85b7731e2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0251567https://doaj.org/toc/1932-6203<h4>Background</h4>Despite China's Expanded Program on Immunization (EPI) provides 2 doses of group A and group C meningococcal polysaccharide vaccine (MPV-AC) for children at 3 years and 6 years old, more self-paying group ACYW135 meningococcal polysaccharide vaccines (MPV-ACYW135) have been used as an alternative to MPV-AC to prevent Neisseria meningitidis serogroup C,Y,W135. We provide recommendations for Chinese booster immunization of meningococcal meningitis vaccine by analyzing the service status of MPV-AC and MPV-ACYW135.<h4>Methods</h4>Reported data of routine immunization coverage from all districts of Hangzhou registered in the China Information Management System For Immunization Programming (CIMSFIP) between 2014 to 2019 were described and evaluated. Descriptive epidemiological methods were used to characterize the data. Adverse event following immunization (AEFI) were collected from Chinese national adverse event following immunization information system (CNAEFIIS) to compare the safety of MPV-AC and MPV-ACYW135.<h4>Results</h4>1376919 doses of booster immunization of meningococcal meningitis vaccine (MenV) in CIMSFIP were conducted in China Hangzhou from 2014 to 2019, with reported immunization coverage rates above 95%. The proportion of children using MPV-ACYW135 increased from 12.63% in 2014 to 29.45% in 2019. The incidence of AEFI of MPV-AC and MPV-ACYW135 were 49.75 per 100,000 and 45.44 per 100,000, respectively, without statistical difference.<h4>Conclusion</h4>Children in Hangzhou had high booster immunization of MenV coverage. The use amount and use rate of MPV-ACYW135 increased year by year, indicating more and more parents had chosen MPV-ACYW135 as an alternative to MPV-AC at their own expense for children. The use proportions of MPV-ACYW135 were different in urban, suburban and rural areas. Both MPV-AC and MPV-ACYW135 were safe for children.Xinren CheYan LiuJun WangYuyang XuXuechao ZhangWenwen GuWei JiangJian DuXiaoping ZhangPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 5, p e0251567 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Xinren Che Yan Liu Jun Wang Yuyang Xu Xuechao Zhang Wenwen Gu Wei Jiang Jian Du Xiaoping Zhang Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
description	<h4>Background</h4>Despite China's Expanded Program on Immunization (EPI) provides 2 doses of group A and group C meningococcal polysaccharide vaccine (MPV-AC) for children at 3 years and 6 years old, more self-paying group ACYW135 meningococcal polysaccharide vaccines (MPV-ACYW135) have been used as an alternative to MPV-AC to prevent Neisseria meningitidis serogroup C,Y,W135. We provide recommendations for Chinese booster immunization of meningococcal meningitis vaccine by analyzing the service status of MPV-AC and MPV-ACYW135.<h4>Methods</h4>Reported data of routine immunization coverage from all districts of Hangzhou registered in the China Information Management System For Immunization Programming (CIMSFIP) between 2014 to 2019 were described and evaluated. Descriptive epidemiological methods were used to characterize the data. Adverse event following immunization (AEFI) were collected from Chinese national adverse event following immunization information system (CNAEFIIS) to compare the safety of MPV-AC and MPV-ACYW135.<h4>Results</h4>1376919 doses of booster immunization of meningococcal meningitis vaccine (MenV) in CIMSFIP were conducted in China Hangzhou from 2014 to 2019, with reported immunization coverage rates above 95%. The proportion of children using MPV-ACYW135 increased from 12.63% in 2014 to 29.45% in 2019. The incidence of AEFI of MPV-AC and MPV-ACYW135 were 49.75 per 100,000 and 45.44 per 100,000, respectively, without statistical difference.<h4>Conclusion</h4>Children in Hangzhou had high booster immunization of MenV coverage. The use amount and use rate of MPV-ACYW135 increased year by year, indicating more and more parents had chosen MPV-ACYW135 as an alternative to MPV-AC at their own expense for children. The use proportions of MPV-ACYW135 were different in urban, suburban and rural areas. Both MPV-AC and MPV-ACYW135 were safe for children.
format	article
author	Xinren Che Yan Liu Jun Wang Yuyang Xu Xuechao Zhang Wenwen Gu Wei Jiang Jian Du Xiaoping Zhang
author_facet	Xinren Che Yan Liu Jun Wang Yuyang Xu Xuechao Zhang Wenwen Gu Wei Jiang Jian Du Xiaoping Zhang
author_sort	Xinren Che
title	Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
title_short	Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
title_full	Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
title_fullStr	Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
title_full_unstemmed	Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.
title_sort	booster immunization of meningococcal meningitis vaccine among children in hangzhou, china, 2014-2019.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/32a1da62d2ae40d69213914a85b7731e
work_keys_str_mv	AT xinrenche boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT yanliu boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT junwang boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT yuyangxu boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT xuechaozhang boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT wenwengu boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT weijiang boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT jiandu boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019 AT xiaopingzhang boosterimmunizationofmeningococcalmeningitisvaccineamongchildreninhangzhouchina20142019
_version_	1718414390922838016

Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019.

Ejemplares similares